AR095132A1 - Formulación en dispersión sólida de un compuesto antiviral - Google Patents
Formulación en dispersión sólida de un compuesto antiviralInfo
- Publication number
- AR095132A1 AR095132A1 ARP140100354A ARP140100354A AR095132A1 AR 095132 A1 AR095132 A1 AR 095132A1 AR P140100354 A ARP140100354 A AR P140100354A AR P140100354 A ARP140100354 A AR P140100354A AR 095132 A1 AR095132 A1 AR 095132A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formulation
- solid dispersion
- antiviral compound
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
Abstract
Se divulgan dispersiones sólidas que comprenden un compuesto que tiene la fórmula (1) caracterizadas porque el compuesto es dispersado dentro de una matriz polimérica formada por un polímero aceptable desde el punto de vista farmacéutico, y caracterizadas además porque el compuesto es sustancialmente amorfo. También, se divulgan las composiciones farmacéuticas que comprenden el compuesto así como los métodos de uso para el compuesto.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361870703P | 2013-08-27 | 2013-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095132A1 true AR095132A1 (es) | 2015-09-30 |
Family
ID=50097890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100354A AR095132A1 (es) | 2013-08-27 | 2014-01-31 | Formulación en dispersión sólida de un compuesto antiviral |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150064252A1 (es) |
AR (1) | AR095132A1 (es) |
TW (1) | TW201511780A (es) |
UY (1) | UY35301A (es) |
WO (1) | WO2015030854A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI607011B (zh) | 2010-11-17 | 2017-12-01 | 基利法瑪席特有限責任公司 | 抗病毒化合物 |
WO2013075029A1 (en) | 2011-11-16 | 2013-05-23 | Gilead Sciences, Inc. | Condensed imidazolylimidazoles as antiviral compounds |
MX2016002185A (es) | 2013-08-27 | 2016-06-06 | Gilead Pharmasset Llc | Formulacion combinada de dos compuestos antivirales. |
TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
CN107343877A (zh) * | 2016-05-06 | 2017-11-14 | 常州爱诺新睿医药技术有限公司 | 一种无定型维帕他维的固体分散体及其制备方法 |
BR102017011025A2 (pt) * | 2016-06-02 | 2017-12-19 | Gilead Pharmasset Llc | Formulation of combination of three antiviral compounds |
HUE056973T2 (hu) | 2016-11-16 | 2022-04-28 | H Lundbeck As | MAGL inhibitor kristályos formája |
JOP20190108B1 (ar) | 2016-11-16 | 2023-09-17 | H Lundbeck As | تركيبات صيدلانية |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858389A (en) * | 1996-08-28 | 1999-01-12 | Shaker H. Elsherbini | Squalene is an antiviral compound for treating hepatitis C virus carriers |
BR0307333A (pt) | 2002-02-01 | 2004-12-07 | Pfizer Prod Inc | Métodos para a preparação de dispersões homogéneas de fármacos sólidos amorfos atomizados utilizando um sistema de secagem por pulverização |
CN100528875C (zh) | 2005-02-18 | 2009-08-19 | 美德(江西)生物科技有限公司 | 无结晶型态的印地普隆及其制备方法 |
BRPI0719395C1 (pt) * | 2006-12-07 | 2021-05-25 | Daiichi Sankyo Co Ltd | tablete revestido de filme |
US20100256184A1 (en) * | 2008-08-13 | 2010-10-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
TWI607011B (zh) * | 2010-11-17 | 2017-12-01 | 基利法瑪席特有限責任公司 | 抗病毒化合物 |
WO2013075029A1 (en) | 2011-11-16 | 2013-05-23 | Gilead Sciences, Inc. | Condensed imidazolylimidazoles as antiviral compounds |
US20130309196A1 (en) * | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
-
2014
- 2014-01-30 WO PCT/US2014/013933 patent/WO2015030854A1/en active Application Filing
- 2014-01-30 US US14/168,313 patent/US20150064252A1/en not_active Abandoned
- 2014-01-31 UY UY35301A patent/UY35301A/es not_active Application Discontinuation
- 2014-01-31 AR ARP140100354A patent/AR095132A1/es unknown
- 2014-02-05 TW TW103103760A patent/TW201511780A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015030854A1 (en) | 2015-03-05 |
UY35301A (es) | 2015-03-27 |
TW201511780A (zh) | 2015-04-01 |
US20150064252A1 (en) | 2015-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY35298A (es) | Formulación en dispersión sólida de un compuesto antiviral | |
AR095132A1 (es) | Formulación en dispersión sólida de un compuesto antiviral | |
CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
CL2017000240A1 (es) | Compuestos activos hacia bromodominios | |
CL2017000902A1 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
UY37435A (es) | Pirrolidinas sustituidas y métodos para usarlas | |
UY37098A (es) | Moduladores de ror-gamma | |
CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015003686A1 (es) | Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades | |
CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
CL2016002877A1 (es) | Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos. | |
ECSP16000724A (es) | Carboxamidas de anillo de 4 miembros empleadas como nematicidas | |
UY35300A (es) | Formulación de combinación de dos compuestos antivirales | |
GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
CL2018000786A1 (es) | Nuevos derivados de pirrolo[2,3-d]pirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
CR20160518A (es) | Compuestos para tratar atrofia muscular espinal | |
NI201800058A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer. | |
CO7210068A1 (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
CO7240372A2 (es) | Formulaciones farmacéuticas tópicas no acuosas | |
CL2019001993A1 (es) | Inhibidores selectivos de jak1. | |
SV2018005760A (es) | Derivados de aminotiazol utiles como agentes antiviricos | |
CL2017000014A1 (es) | Derivados de isondolina para su uso en el tratamiento de una infección viral | |
CR20160438A (es) | Dispersión sólida amorfa que comprende taxano, comprimido que comprende la misma, y método para su preparación | |
PH12016500793A1 (en) | Turmeric extract containing soft pastilles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |